Three-year longitudinal assessment of denosumab's efficacy and safety in postmenopausal osteoporosis: a 36-month real-world cohort study.
Saved in:
| Title: | Three-year longitudinal assessment of denosumab's efficacy and safety in postmenopausal osteoporosis: a 36-month real-world cohort study. |
|---|---|
| Authors: | Xia RL; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China.; Department of Osteo-Internal Medicine, Tianjin Hospital, Tianjin, China., Li C; Department of Orthopaedics, Tianjin Hospital, Tianjin, China., Wang L; Department of Osteo-Internal Medicine, Tianjin Hospital, Tianjin, China., Chao AJ; Department of Osteo-Internal Medicine, Tianjin Hospital, Tianjin, China., Wei W; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2026 Jul 14; Vol. 13, pp. 1825383. Date of Electronic Publication: 2026 Jul 14 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
